Press Releases
GLW Announces Full Market Release of the Apollo Ankle Fracture Plating System
Englewood Cliffs, NJ., — GLW Foot & Ankle (Carbon22), a GLW Medical Innovation company (“GLW” or “Company”) with a focus on the foot and ankle orthopedic market is excited to announce the full market release of its Apollo Ankle Fracture (AFX) Plating System. The Company has commercialized its patented, first of its kind, additive manufactured … Continued
GLW Announces Additional FDA 510(K) Clearance for the Artemis Proximal Femoral Nail System
NEW LONG NAIL TO STRENGTHEN THE ARTEMIS SYSTEM AND STREAMLINE WORKFLOWS ENGLEWOOD CLIFFS, NJ, USA, October 31, 2022 / – GLW Trauma, a GLW Medical Innovation (GLW) company focused on a paradigm shift in the surgical treatment of trochanteric hip fractures, announced today an additional U.S. Food and Drug Administration (FDA) 510(k) clearance of the … Continued
GLW Receives FDA 510(k) Clearance for Apollo Ankle Fracture Plating System
Englewood Cliffs, NJ., — GLW Foot & Ankle (Carbon22), a GLW Medical Innovation company (GLW) with a focus on the foot and ankle orthopedic market, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its upcoming Apollo Ankle Fracture (AFX) Plating System, a novel portfolio of see-through, … Continued
Solvay and GLW partner on Creed™ Cannulated Compression Screws for orthopedics
Alpharetta, Ga., — Solvay’s Zeniva® polyetheretherketone (PEEK) resin was chosen by GLW Foot & Ankle (Carbon22), a GLW Medical Innovation company for its new Creed™ Cannulated Screw System for foot and ankle surgery. This advanced new screw system recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA). To create the new system’s ortholucent, plastic-metal hybrid … Continued
GLW Announces FDA 510(K) Clearance for the Artemis Proximal Femoral Nail System
A FOURTH-GENERATION HIP FRACTURE NAIL MANUFACTURED USING A REVOLUTIONARY PROCESS ENGLEWOOD CLIFFS, NJ, USA, February 22, 2021 / – GLW Trauma, a GLW Medical Innovation (GLW) company announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Artemis Proximal Femoral Nail (PFN) System, a hip fracture nail. The … Continued
GLW Receives FDA 510(k) Clearance for the Creed™ Cannulated Screw System
ENGLEWOOD CLIFFS, NJ, USA, December 17, 2020 — GLW Foot & Ankle (Carbon22), a GLW Medical Innovation Company, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market the Creed™ Cannulated Screw System, a portfolio of unique, see-through “ortholucent” bone screws used for foot and ankle surgery. … Continued
GLW Receives FDA 510(k) Clearance for FusionFrame™ Ring Lock System
Carbon22 Consortium designed circular external fixator can treat complex foot and ankle deformities as well as provide a static frame for various indications. ENGLEWOOD CLIFFS, NJ, USA, September 29, 2020 — GLW Foot & Ankle (Carbon22), a GLW Medical Innovation company announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration … Continued